Cover Image

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis

Lijun Xu,1 Hongwen Lan,1 Yushu Su,1 Jun Li,1 Jingwen Wan2 1Department of Cardiothoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Department of Surgery (Operation Room), Tongji Hospital, Tongji Medical College, Huazhong Universi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xu L (Author), Lan H (Author), Su Y (Author), Li J (Author), Wan J (Author)
Format:	Book
Published:	Dove Medical Press, 2015-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological significance and potential drug target of RUNX3 in breast cancer
by: Yu YY, et al.
Published: (2014)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
by: Zhou X, et al.
Published: (2015)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
by: Wang Z, et al.
Published: (2014)

Clinicopathological significance and a potential drug target of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review
by: Song X, et al.
Published: (2016)

The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
by: Su Y, et al.
Published: (2015)

Comments on a meta-analysis and systematic review of the clinicopathological significance of CDH1 in gastric cancer
by: Tu C, et al.
Published: (2016)

A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer
by: Shi H, et al.
Published: (2015)

Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis
by: Miao S, et al.
Published: (2015)

Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review
by: Yu Q, et al.
Published: (2015)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
by: Wu X, et al.
Published: (2016)

Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer
by: Kocdor H, et al.
Published: (2015)

Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
by: Huang R, et al.
Published: (2015)

A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
by: Zhang C, et al.
Published: (2015)

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
by: Guo L, et al.
Published: (2015)

Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma
by: Li J, et al.
Published: (2014)

The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
by: Chen Q, et al.
Published: (2015)

Non-small Cell Lung Cancer with Concomitant , , and Mutation: Clinicopathologic Features of 12 Cases
by: Taebum Lee, et al.
Published: (2016)

Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
by: You Q, et al.
Published: (2015)

MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
by: Lisi Yuan, et al.
Published: (2023)

Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer
by: Jialin Su, et al.
Published: (2024)

Prognostic Significance of Aquaporin 5 Expression in Non-small Cell Lung Cancer
by: Young Min Jo, et al.
Published: (2016)

Impact of potential inappropriate NSAIDs use in chronic pain
by: Ussai S, et al.
Published: (2015)

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold
by: Zhang Y, et al.
Published: (2015)

The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review
by: Zeng W, et al.
Published: (2015)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
by: Jia-Qi Xu, et al.
Published: (2022)

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
by: Navari RM
Published: (2014)

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023)

Targeting the hypoxia pathway to treat pancreatic cancer
by: Erickson LA, et al.
Published: (2015)

Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors
by: Amir Hossein Jafarian, et al.
Published: (2020)

Comparison of anterior decompression and fusion versus laminoplasty in the treatment of multilevel cervical ossification of the posterior longitudinal ligament: a systematic review and meta-analysis
by: Liu W, et al.
Published: (2016)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
by: Squitieri F, et al.
Published: (2015)

Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action
by: Mengyuan Han, et al.
Published: (2024)

Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy
by: Chen Yan, et al.
Published: (2022)

Recent progress in targeted therapy for non-small cell lung cancer
by: Yanxia Xiao, et al.
Published: (2023)

Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients
by: Ola Abu Al Karsaneh, et al.
Published: (2023)

Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
by: Gaurav Garg, et al.
Published: (2021)

Distribution and Clinical Significance of IL-17A in Tumor-Infiltrating Lymphocytes of Non-Small Cell Lung Cancer Patients
by: Rui Xu, et al.
Published: (2022)

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection [Expression of concern]
by: Gao F, et al.
Published: (2020)

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
by: Soomin Ahn, et al.
Published: (2016)

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells
by: Amineh Ghaderi, et al.
Published: (2023)